Clinical Trials Logo

Premenstrual Syndrome clinical trials

View clinical trials related to Premenstrual Syndrome.

Filter by:

NCT ID: NCT06176313 Recruiting - Clinical trials for Premenstrual Syndrome

Effects of Training Given to Cope With Premenstrual Syndrome and Mandala Activity on Premenstrual Symptoms

MANDALA
Start date: October 25, 2023
Phase: N/A
Study type: Interventional

The research employs a pre-test post-test control group design with a randomized controlled semi-experimental approach to determine the impact of education provided for coping with premenstrual syndrome and Mandala activity on premenstrual symptoms. Research Hypotheses: H01: Mandala activity is not effective in reducing premenstrual symptoms. H02: Education provided for coping with premenstrual syndrome is not effective in reducing premenstrual symptoms. H13: Mandala activity is effective in reducing premenstrual symptoms. H14: Education provided for coping with premenstrual syndrome is effective in reducing premenstrual symptoms. H15: Mandala activity is more effective than education provided for coping with premenstrual syndrome in reducing premenstrual symptoms among students with PMS. Research Groups: Mandala Group, Coping with Premenstrual Symptoms Education Group, and Control Group.

NCT ID: NCT06173661 Not yet recruiting - Migraine Clinical Trials

Fremanezumab Treatment of Migraine in Women With Menstrual Migraine Ages 18-45

Start date: January 2024
Phase: Phase 4
Study type: Interventional

The goal of this clinical trial is to learn about how a migraine prevention medicine works for people who have migraines/headaches with their menstrual period. The study includes people ages 18 to 45 who have been diagnosed with migraine and who have a migraine with their menstrual period or those who have migraines with their menstrual period and at other times of the month as well. The main question the study aims to answer are: • Does fremanazemab, an injectable calcitonin gene-related peptide (CGRP) pathway targeting therapy, decrease migraines associated with menstruation? Participants will - have an evaluation and examination by a headache specialist physician - will receive the study medicine or inactive substitute every three months for two treatments - fill out diaries about their migraines - have tests on saliva to measure hormone levels Researchers will compare the people who get the medicine to those who get the inactive substitute to see if there are differences in response.

NCT ID: NCT06146673 Recruiting - Sleep Clinical Trials

A Multidimensional Study of Premenstrual Syndrome and Body Image

Start date: September 1, 2023
Phase:
Study type: Observational

The goal of this cross-sectional study is to investigate the influencing factors of body image in women of reproductive age. The main question[s] it aims to answer are: - Is there a connection between physical activity, body mass index and body image? - Is there a connection between body image, premenstrual syndrome and sleep quality? Participants will fill out a complex online questionnaire.

NCT ID: NCT06144073 Recruiting - Clinical trials for Premenstrual Syndrome

The Effect of Mandala Art Therapy in Coping With Premenstrual Syndrome

Start date: October 6, 2022
Phase: N/A
Study type: Interventional

Mandala practice will be applied to women with premenstrual syndrome. The intervention group (Mandala practice group) and the control group each consisted of 60 women.

NCT ID: NCT06136104 Active, not recruiting - Healthy Clinical Trials

The Effects of Mixhers HERTIME Supplements on Menstrual Symptoms

Start date: August 30, 2023
Phase: N/A
Study type: Interventional

The purpose of this study is to assess Mixhers HERTIME supplements efficacy in alleviating menstrual cycle symptoms.

NCT ID: NCT06124326 Active, not recruiting - Clinical trials for Premenstrual Syndrome

A Single Group Study to Evaluate the Effects of a Supplement on Premenstrual Syndrome

Start date: August 31, 2023
Phase: N/A
Study type: Interventional

This is a virtual single-group study that will last three menstrual cycles (approximately 12 weeks). During the first menstrual cycle, participants will take the supplement as needed (pro re nata) when they feel symptoms of PMS, such as cramping or bloating. For the second and third menstrual cycles, Participants will take 2 capsules per day with water for 1 week, starting 4 days before their menstrual cycle and finishing on Day 3 of their cycle. Questionnaires will be completed at the following time points: - Baseline - Day 7 of their first cycle during the trial (After using the product PRN during their period) - 4 days before their second period during the trial (After using the product PRN for the previous month) - Day 3 of their second period during the trial (After using the product for 7 days straight) - Day 3 of their third period of the trial (After using the product for 7 days straight)

NCT ID: NCT06124300 Active, not recruiting - Clinical trials for Polycystic Ovary Syndrome

Effects of a Female Hormone Balance Supplement on Symptoms of Polycystic Ovary Syndrome and Severe Premenstrual Syndrome

Start date: August 30, 2023
Phase: N/A
Study type: Interventional

This is a virtual single group study that will last 12 weeks. Participants will take 1 scoop of the female hormone balance supplement, and mix it with their drink of choice every morning. Questionnaires will be completed at baseline, 1 week, 2 weeks, 4 weeks, and 12 weeks

NCT ID: NCT06117215 Not yet recruiting - Clinical trials for Premenstrual Syndrome

Prevalence of Premenstrual Syndrome in Women of Reproductive Age

Sd-Premens
Start date: December 1, 2023
Phase:
Study type: Observational

The menstrual cycle is a recurring process in the lives of women from puberty until menopause. This cycle can cause various discomforts, including premenstrual syndrome. Described differently, premenstrual syndrome is a collection of physical and psychological symptoms that occur during the luteal phase of the menstrual cycle and subside upon the arrival of menstruation. This definition is conditioned by the existence of a free interval of at least one week between the end of the period and the appearance of these symptoms, as well as a global impairment of functioning and quality of life for women. The impact on the personal, social, and professional lives of affected women, as well as the pain and discomfort it causes, may be perceived as insignificant or normal by women. Therefore, few women report the existence of these disorders to healthcare professionals. As the subject is not approached, these women are not taken care of even though therapeutic solutions could be proposed. This pathology affects a large number of women, but its prevalence differs greatly depending on the studies conducted on the subject, suggesting a lack of knowledge of this syndrome.

NCT ID: NCT06105567 Recruiting - Clinical trials for Premenstrual Syndrome

The Effect of Education Given According to the Health Promotion Model on Premenstrual Symptoms, Emotional Eating Behavior and Perceived Stress

Premenstrual
Start date: October 30, 2023
Phase: N/A
Study type: Interventional

Nurses have important duties in this regard due to their roles such as health education, health protection, development and consultancy. In this study, it is thought that the training given according to the health promotion model will both create a resource for nurses and contribute to the literature with the results obtained by applying this training to people experiencing PMS.The research will be conducted as a pretest-posttest randomized controlled study. H1: Education given according to the health promotion model has an effect on premenstrual symptoms, emotional eating behavior and perceived stress. H0: Education given according to the health promotion model has no effect on premenstrual symptoms, emotional eating behavior and perceived stress. The total number of students in the research population is 330.In the G*Power 3.1.9.7 program, for the effect size t test, d = 0.94, alpha (α) = 0.05, and power (1-β) = 0.95, and the minimum total sample number was determined as 52, experimental group: 26, control group: 26. . However, taking into account the losses in the study, a total of 60 people will be included in the study. (experiment:30, control:30). The first group will be divided into the group trained according to the health promotion model using the Philips 66 technique, and the second group will be divided into the control group.

NCT ID: NCT06052722 Not yet recruiting - Clinical trials for Temporomandibular Disorder

The Relationship of Premenstrual Syndrome and Primary Dysmenorrhea With Severity of Temporomandibular Disorders

Start date: October 1, 2023
Phase: N/A
Study type: Interventional

Premenstrual pain, menstrual pain, other pains, and somatic symptoms may occur together. Therefore, this study aims to examine the severity of temporomandibular disorders in individuals complaining of premenstrual syndrome or dysmenorrhea and its relationship.